Measurement of haemolysis markers following transfusion of uncrossmatched, low-titre, group O+ whole blood in civilian trauma patients: initial experience at a level 1 trauma centre

Transfusion Medicine

Volumn 27, Issue 1, 2017, Pages 30-35

  Seheult, J N ^a   Triulzi, D J ^a,b   Alarcon, L H ^c   Sperry, J L ^c   Murdock, A ^c   Yazer, M H ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

adverse events; civilian; haemolysis; resuscitation; transfusion; trauma; whole blood

Indexed keywords

BILIRUBIN; BIOCHEMICAL MARKER; BLOOD GROUP A ANTIBODY; BLOOD GROUP B ANTIBODY; CREATININE; HAPTOGLOBIN; LACTATE DEHYDROGENASE; POTASSIUM; BIOLOGICAL MARKER; BLOOD GROUP ABO SYSTEM;

ADULT; ARTICLE; BLEEDING; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP O; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; ERYTHROCYTE; EXPERIENCE; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; HYPOTENSION; INJURY; MALE; MEASUREMENT; POTASSIUM BLOOD LEVEL; RESUSCITATION; THROMBOCYTE; BLOOD; BLOOD GROUP ABO SYSTEM; EMERGENCY HEALTH SERVICE; METABOLISM; MIDDLE AGED; WOUNDS AND INJURIES;

ABO BLOOD-GROUP SYSTEM; ADULT; BILIRUBIN; BIOMARKERS; BLOOD TRANSFUSION; CREATININE; FEMALE; HAPTOGLOBINS; HEMOLYSIS; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; POTASSIUM; TRAUMA CENTERS; WOUNDS AND INJURIES;

EID: 84995460822     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/tme.12372     Document Type: Article

References (19)

1. Baker, S.P., O'Neill, B., Haddon, W. Jr. & Long, W.B. (1974) The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. Journal of Trauma, 14, 187–196.
2. Berseus, O., Boman, K., Nessen, S.C. & Westerberg, L.A. (2013) Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Transfusion, 53 (Suppl. 1), 114S–123S.
3. Cotton, B.A., Podbielski, J., Camp, E. et al. (2013) A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Annals of Surgery, 258, 527–532; discussion 532-523.
4. Daniel-Johnson, J., Leitman, S., Klein, H., Alter, H., Lee-Stroka, A., Scheinberg, P., Pantin, J. & Quillen, K. (2009) Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion, 49, 1845–1849.
5. Dunbar, N.M., Ornstein, D.L. & Dumont, L.J. (2012) ABO incompatible platelets: risks versus benefit. Current Opinion in Hematology, 19, 475–479.
6. Hall, S. & Murphy, M.F. (2015) Limitations of component therapy for massive haemorrhage: is whole blood the whole solution? Anaesthesia, 70, 511–514.
7. Jobes, D., Wolfe, Y., O'Neill, D., Calder, J., Jones, L., Sesok-Pizzini, D. & Zheng, X.L. (2011) Toward a definition of "fresh" whole blood: an in vitro characterization of coagulation properties in refrigerated whole blood for transfusion. Transfusion, 51, 43–51.
8. Josephson, C.D., Castillejo, M.I., Grima, K. & Hillyer, C.D. (2010) ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies. Transfusion and Apheresis Science, 42, 83–88.
9. Kornblith, L.Z., Howard, B.M., Cheung, C.K. et al. (2014) The whole is greater than the sum of its parts: hemostatic profiles of whole blood variants. Journal of Trauma and Acute Care Surgery, 77, 818–827.
10. Lozano, M. & Cid, J. (2003) The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfusion Medicine Reviews, 17, 57–68.
11. Maekawa, M. (1988) Lactate dehydrogenase isoenzymes. Journal of Chromatography, 429, 373–398.
12. Nair, P.M., Pidcoke, H.F., Cap, A.P. & Ramasubramanian, A.K. (2014) Effect of cold storage on shear-induced platelet aggregation and clot strength. Journal of Trauma and Acute Care Surgery, 77, S88–S93.
13. Pidcoke, H.F., McFaul, S.J., Ramasubramanian, A.K. et al. (2013) Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time. Transfusion, 53 (Suppl. 1), 137S–149S.
14. Reddoch, K.M., Pidcoke, H.F., Montgomery, R.K., Fedyk, C.G., Aden, J.K., Ramasubramanian, A.K. & Cap, A.P. (2014) Hemostatic function of apheresis platelets stored at 4 degrees C and 22 degrees C. Shock, 41 (Suppl. 1), 54–61.
15. Strandenes, G., Austlid, I., Apelseth, T.O. et al. (2015) Coagulation function of stored whole blood is preserved for 14 days in austere conditions: a ROTEM feasibility study during a Norwegian antipiracy mission and comparison to equal ratio reconstituted blood. Journal of Trauma and Acute Care Surgery, 78, S31–S38.
16. Yazer, M.H., Glackin, E.M., Triulzi, D.J., Alarcon, L.H., Murdock, A. & Sperry, J. (2016a) The effect of stationary versus rocked storage of whole blood on red blood cell damage and platelet function. Transfusion, 56, 596–604.
17. Yazer, M.H., Jackson, B., Sperry, J.L., Alarcon, L., Triulzi, D.J. & Murdock, A.D. (2016b) Initial safety and feasibility of cold-stored uncrossmatched whole blood transfusion in civilian trauma patients. Journal of Trauma and Acute Care Surgery, 81, 21–26.
18. Yazer, M.H., Deandrade, D.S., Triulzi, D.J., Wisniewski, M.K. & Waters, J.H. (2016c) Electronic enhancements to blood ordering reduce component waste. Transfusion, 56, 564–570.
19. Zielinski, M.D., Jenkins, D.H., Hughes, J.D., Badjie, K.S. & Stubbs, J.R. (2014) Back to the future: the renaissance of whole-blood transfusions for massively hemorrhaging patients. Surgery, 155, 883–886.